HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal, Estee Lauder Virtual Try-On Tools Captured User Biometrics Without Consent – Plaintiff

Executive Summary

Biometric litigation has been stacking up in state and federal courts, including suits targeting cosmetics companies for alleged consumer privacy violations associated with virtual try-on tools. L’Oreal and The Estee Lauder Companies are among the latest to be hit with proposed class actions in Illinois federal court.

You may also be interested in...



Estee Lauder Companies Dismisses BIPA Suit Over Cosmetic Virtual Try-Ons

The US District Court for the Northern District of Illinois grants Estee Lauder Companies’ request to dismiss an amended class action complaint alleging the cosmetics firm collected visitors’ biometric data on branded sites without informing them. Plaintiffs have until 9 February to amend their complaint again.

Sephora Settles California Consumer Privacy Suit; Beauty Retail News

“My office is watching, and we will hold you accountable,” says California’s attorney in a 24 August release announcing settlement with Sephora over alleged violations of the state’s Consumer Privacy Act. More beauty retail news.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel